José
Palacios Calvo
Profesor/a Titular Universidad
Hospital Universitario Arnau de Vilanova
Lleida, EspañaPublications in collaboration with researchers from Hospital Universitario Arnau de Vilanova (22)
2023
-
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
International journal of molecular sciences, Vol. 24, Núm. 13
2022
-
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study
Virchows Archiv, Vol. 480, Núm. 5, pp. 1031-1039
-
Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents
Virchows Archiv, Vol. 481, Núm. 3, pp. 505-509
2019
-
Clinical challenges and implications of intratumor heterogeneity
Revista Espanola de Patologia, Vol. 52, Núm. 4, pp. 234-241
-
Molecular basis of tumor heterogeneity in endometrial carcinosarcoma
Cancers, Vol. 11, Núm. 7
2016
-
Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
Journal of the National Cancer Institute, Vol. 108, Núm. 6
2015
-
A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer
Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503
2014
-
A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry
Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403
2013
-
Endometrial carcinoma: Molecular alterations involved in tumor development and progression
Oncogene, Vol. 32, Núm. 4, pp. 403-413
-
Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis
Human Pathology, Vol. 44, Núm. 2, pp. 244-254
-
ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma
Modern Pathology, Vol. 26, Núm. 11, pp. 1514-1524
2012
-
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia
Histopathology, Vol. 60, Núm. 3, pp. 460-471
2011
-
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels
American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543
-
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma
Journal of Pathology, Vol. 223, Núm. 1, pp. 72-80
2009
-
Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16
2006
-
PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations
Human Pathology, Vol. 37, Núm. 11, pp. 1465-1472
2005
-
Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities
Modern Pathology, Vol. 18, Núm. 5, pp. 719-727
-
Survivin expression in endometrial carcinoma: A tissue microarray study with correlation with PTEN and STAT-3
International Journal of Gynecological Pathology, Vol. 24, Núm. 3, pp. 247-253
2004
-
Abnormalities in the NF-κB family and related proteins in endometrial carcinoma
Journal of Pathology, Vol. 204, Núm. 5, pp. 569-577
2003
-
Abnormalities of E- and P-cadherin and catenin (β-, γ-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia
Journal of Pathology, Vol. 199, Núm. 4, pp. 471-478